Emerging research suggests that IFN signaling plays an important role in the tumor microenvironment and affects anti-cancer therapies differentially (Diamond and Farzan, 2013; Liu et al., 2018; Patin et al., 2018). The gene discussed is IFNA1; the disease is neoplasm.